Suppression of OKT3-induced tumor necrosis factor alpha formation by pentoxifylline in renal transplant recipients.
Leimenstoll
G
G
Department of Nephrology, University of Kiel, Germany.
Zabel
P
P
Schroeder
P
P
Schlaak
M
M
Niedermayer
W
W
D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000379:methods; D015850:Interleukin-6 / Q000097:blood; D016209:Interleukin-8 / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D016853:Muromonab-CD3 / Q000009:adverse effects* / Q000627:therapeutic use; D010431:Pentoxifylline / Q000627:therapeutic use*; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000096:biosynthesis*
D015850:Interleukin-6; D016209:Interleukin-8; D016853:Muromonab-CD3; D014409:Tumor Necrosis Factor-alpha; D010431:Pentoxifylline; D006854:Hydrocortisone